FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2531122050> ?p ?o ?g. }

• W2531122050 endingPage "4080" @default.
• W2531122050 startingPage "4080" @default.
• W2531122050 abstract "4080 DNA double strand breaks (DSB) are profoundly cytotoxic unless rapidly repaired. Non-homologous end joining (NHEJ) is the predominant pathway of repair in mammalian cells. DNA-dependent protein kinase (DNA-PK), a member of the PI3-kinase like kinase (PIKK) family, is an essential component of NHEJ. DNA-PK inhibition is therefore an attractive target for radio- and chemosensitisation in cancer therapy.
 We have developed a series of DNA-PK inhibitors of increasing potency culminating in KU-0060648, IC50 = 8.6 nM with 20-1000-fold selectivity for DNA-PK over other PIKKs and a panel of 60 kinases. At non-cytotoxic concentrations KU-0060648 (≤ 1 μM) increased the cytotoxicity of the topoisomerase II poisons, doxorubicin and etoposide, in a panel of human cancer cell lines. Potentiation of 100 nM doxorubicin cytotoxicity ranged from 3-fold in MDA-MB-231 cells to 107-fold in MCF7 cells and potentiation of 1 μM etoposide cytotoxicity ranged from 3-fold in MDA-MB-231 cells to 105-fold in SW620 cells. KU-0060648 increased doxorubicin-dependent H2AX phosphorylation, consistent with increased DNA damage resulting in cytotoxicity. Studies in DNA-PK proficient and deficient cells demonstrated that chemo and radio-sensitisation by KU-0060648 was DNA-PK specific.
 KU-0060648 has been administered i.v. (25 mg/kg), i.p. (25 mg/kg) and p.o (100 mg/kg) to mice without adverse toxicity. Plasma and tissue pharmacokinetic studies show that tumour levels commensurate with sensitisation in vitro can be maintained for at least 4 hours following administration of 10 mg/kg i.p. KU-0060648 showed 100% bioavailability by oral administration at 10mg/kg, and a t1/2 of >2h. Pharmacodynamic assays demonstrate inhibition of DNA-PK activity in tumours. In mice bearing SW620 xenografts the etoposide (10 mg/kg dailyx5)-induced tumour growth delay of 0.5 days was significantly extended to 5 days by KU-0060648 (10 mg/kg 2xdailyx5).
 In conclusion, KU-0060648 is a potent and selective DNA-PK inhibitor. It has acceptable PK and DNA-PK is inhibited in target tissues at tolerable doses. It is a potent chemosensitiser in models of common human malignancies in vitro and in vivo." @default.
• W2531122050 created "2016-10-21" @default.
• W2531122050 creator A5001428394 @default.
• W2531122050 creator A5001447451 @default.
• W2531122050 creator A5016620418 @default.
• W2531122050 creator A5037778274 @default.
• W2531122050 creator A5041800911 @default.
• W2531122050 creator A5046060433 @default.
• W2531122050 creator A5062272522 @default.
• W2531122050 creator A5063002799 @default.
• W2531122050 creator A5071972700 @default.
• W2531122050 creator A5073138155 @default.
• W2531122050 creator A5081302297 @default.
• W2531122050 creator A5081904629 @default.
• W2531122050 creator A5086547100 @default.
• W2531122050 date "2008-05-01" @default.
• W2531122050 modified "2023-09-26" @default.
• W2531122050 title "Chemosensitisation of cancer cells by KU-0060648, a potent and selective inhibitor of DNA-PK [abstract]" @default.
• W2531122050 hasPublicationYear "2008" @default.
• W2531122050 type Work @default.
• W2531122050 sameAs 2531122050 @default.
• W2531122050 citedByCount "0" @default.
• W2531122050 crossrefType "journal-article" @default.
• W2531122050 hasAuthorship W2531122050A5001428394 @default.
• W2531122050 hasAuthorship W2531122050A5001447451 @default.
• W2531122050 hasAuthorship W2531122050A5016620418 @default.
• W2531122050 hasAuthorship W2531122050A5037778274 @default.
• W2531122050 hasAuthorship W2531122050A5041800911 @default.
• W2531122050 hasAuthorship W2531122050A5046060433 @default.
• W2531122050 hasAuthorship W2531122050A5062272522 @default.
• W2531122050 hasAuthorship W2531122050A5063002799 @default.
• W2531122050 hasAuthorship W2531122050A5071972700 @default.
• W2531122050 hasAuthorship W2531122050A5073138155 @default.
• W2531122050 hasAuthorship W2531122050A5081302297 @default.
• W2531122050 hasAuthorship W2531122050A5081904629 @default.
• W2531122050 hasAuthorship W2531122050A5086547100 @default.
• W2531122050 hasConcept C109316439 @default.
• W2531122050 hasConcept C121608353 @default.
• W2531122050 hasConcept C143425029 @default.
• W2531122050 hasConcept C147897179 @default.
• W2531122050 hasConcept C153911025 @default.
• W2531122050 hasConcept C154317977 @default.
• W2531122050 hasConcept C184235292 @default.
• W2531122050 hasConcept C185592680 @default.
• W2531122050 hasConcept C202751555 @default.
• W2531122050 hasConcept C2776694085 @default.
• W2531122050 hasConcept C2778119113 @default.
• W2531122050 hasConcept C2781303535 @default.
• W2531122050 hasConcept C502942594 @default.
• W2531122050 hasConcept C54355233 @default.
• W2531122050 hasConcept C552990157 @default.
• W2531122050 hasConcept C55493867 @default.
• W2531122050 hasConcept C86803240 @default.
• W2531122050 hasConcept C96232424 @default.
• W2531122050 hasConcept C98274493 @default.
• W2531122050 hasConceptScore W2531122050C109316439 @default.
• W2531122050 hasConceptScore W2531122050C121608353 @default.
• W2531122050 hasConceptScore W2531122050C143425029 @default.
• W2531122050 hasConceptScore W2531122050C147897179 @default.
• W2531122050 hasConceptScore W2531122050C153911025 @default.
• W2531122050 hasConceptScore W2531122050C154317977 @default.
• W2531122050 hasConceptScore W2531122050C184235292 @default.
• W2531122050 hasConceptScore W2531122050C185592680 @default.
• W2531122050 hasConceptScore W2531122050C202751555 @default.
• W2531122050 hasConceptScore W2531122050C2776694085 @default.
• W2531122050 hasConceptScore W2531122050C2778119113 @default.
• W2531122050 hasConceptScore W2531122050C2781303535 @default.
• W2531122050 hasConceptScore W2531122050C502942594 @default.
• W2531122050 hasConceptScore W2531122050C54355233 @default.
• W2531122050 hasConceptScore W2531122050C552990157 @default.
• W2531122050 hasConceptScore W2531122050C55493867 @default.
• W2531122050 hasConceptScore W2531122050C86803240 @default.
• W2531122050 hasConceptScore W2531122050C96232424 @default.
• W2531122050 hasConceptScore W2531122050C98274493 @default.
• W2531122050 hasLocation W25311220501 @default.
• W2531122050 hasOpenAccess W2531122050 @default.
• W2531122050 hasPrimaryLocation W25311220501 @default.
• W2531122050 hasRelatedWork W1489256324 @default.
• W2531122050 hasRelatedWork W1508136706 @default.
• W2531122050 hasRelatedWork W1561052663 @default.
• W2531122050 hasRelatedWork W1837926236 @default.
• W2531122050 hasRelatedWork W1969749544 @default.
• W2531122050 hasRelatedWork W1974539652 @default.
• W2531122050 hasRelatedWork W1980001514 @default.
• W2531122050 hasRelatedWork W2026372836 @default.
• W2531122050 hasRelatedWork W2123122265 @default.
• W2531122050 hasRelatedWork W2130932693 @default.
• W2531122050 hasRelatedWork W2162584257 @default.
• W2531122050 hasRelatedWork W2167223999 @default.
• W2531122050 hasRelatedWork W2264268250 @default.
• W2531122050 hasRelatedWork W2404690244 @default.
• W2531122050 hasRelatedWork W2564461514 @default.
• W2531122050 hasRelatedWork W2918225842 @default.
• W2531122050 hasRelatedWork W2921785857 @default.
• W2531122050 hasRelatedWork W2997471719 @default.
• W2531122050 hasRelatedWork W3044176782 @default.
• W2531122050 hasRelatedWork W2765211159 @default.
• W2531122050 hasVolume "68" @default.

• next